ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson’s disease therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Parkinson’s disease (PD), characterized by dopaminergic neuron degeneration in the substantia nigra, is caused by various genetic and environmental factors. Current treatment methods are medication and surgery; however, a primary therapy has not yet been proposed. In this study, we aimed to develop a new treatment for PD that induces direct reprogramming of dopaminergic neurons (iDAN). Achaete-scute family bHLH transcription factor 1 (ASCL1) is a primary factor that initiates and regulates central nervous system development and induces neurogenesis. In addition, it interacts with BRN2 and MYT1L, which are crucial transcription factors for the direct conversion of fibroblasts into neurons. Overexpression of ASCL1 along with the transcription factors NURR1 and LMX1A can directly reprogram iDANs. Using a retrovirus, GFP-tagged ASCL1 was overexpressed in astrocytes. One week of culture in iDAN convertsion medium reprogrammed the astrocytes into iDANs. After 7 days of differentiation, TH+/TUJ1+ cells emerged. After 2 weeks, the number of mature TH+/TUJ1+ dopaminergic neurons increased. Only ventral midbrain (VM) astrocytes exhibited these results, not cortical astrocytes. Thus, VM astrocytes can undergo direct iDAN reprogramming with ASCL1 alone, in the absence of transcription factors that stimulate dopaminergic neurons development.
Abstract
Parkinson’s disease (PD), characterized by dopaminergic neuron degeneration in the substantia nigra, is caused by various genetic and environmental factors. Current treatment methods are medication and surgery; however, a primary therapy has not yet been proposed. In this study, we aimed to develop a new treatment for PD that induces direct reprogramming of dopaminergic neurons (iDAN). Achaete-scute family bHLH transcription factor 1 (ASCL1) is a primary factor that initiates and regulates central nervous system development and induces neurogenesis. In addition, it interacts with BRN2 and MYT1L, which are crucial transcription factors for the direct conversion of fibroblasts into neurons. Overexpression of ASCL1 along with the transcription factors NURR1 and LMX1A can directly reprogram iDANs. Using a retrovirus, GFP-tagged ASCL1 was overexpressed in astrocytes. One week of culture in iDAN convertsion medium reprogrammed the astrocytes into iDANs. After 7 days of differentiation, TH+/TUJ1+ cells emerged. After 2 weeks, the number of mature TH+/TUJ1+ dopaminergic neurons increased. Only ventral midbrain (VM) astrocytes exhibited these results, not cortical astrocytes. Thus, VM astrocytes can undergo direct iDAN reprogramming with ASCL1 alone, in the absence of transcription factors that stimulate dopaminergic neurons development.
참고문헌 (24)
- McGregor MM, "Circuit mechanisms of Parkinson’s disease", Neuron, 101, pp.1042~1056 (2019)
- Group PS, "Levodopa and the progression of Parkinson’s disease", N Engl J Med, 351, pp.2498~2508 (2004)
- Fabbrini G, "Levodopa-induced dyskinesias", Mov Disord, 22, pp.1379~1389 (2007)
- Freed CR, "Transplantation of embryonic dopamine neurons for severe Parkinson’s disease", N Engl J Med, 344, pp.710~719 (2001)
- Björklund LM, "Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model", Proc Natl Acad Sci U S A, 99, pp.2344~2349 (2002)
- Hallett PJ, "Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson’s disease", Cell Stem Cell, 16, pp.269~274 (2015)
- Pfisterer U, "Direct conversion of human fibroblasts to dopaminergic neurons", Proc Natl Acad Sci U S A, 108, pp.10343~10348 (2011)
- Pang ZP, "Induction of human neuronal cells by defined transcription factors", Nature, 476, pp.220~223 (2011)
- Siracusa R, "Astrocytes : role and functions in brain pathologies", Front Pharmacol, 10, pp.1114~ (2019)
- Wapinski OL, "Rapid chromatin switch in the direct reprogramming of fibroblasts to neurons", Cell Rep, 20, pp.3236~3247 (2017)
- Rao Z, "Molecular mechanisms underlying ascl1-mediated astrocyte-to-neuron conversion", Stem Cell Reports, 16, pp.534~547 (2021)
- Chanda S, "Generation of induced neuronal cells by the single reprogramming factor ASCL1", Stem Cell Reports, 3, pp.282~296 (2014)
- Sohn J, "Efficient neuronal direct conversion of mouse astrocytes by ASCL1 dephosphorylation", Master, pp.2021
- Han JY, "Efficient generation of dopaminergic neurons from mouse ventral midbrain astrocytes", Biomol Ther(Seoul), 31, pp.264~275 (2023)
- Antoni D, "Threedimensional cell culture : a breakthrough in vivo", Int J Mol Sci, 16, pp.5517~5527 (2015)
- Zhou S, "Neurosphere based differentiation of human iPSC improves astrocyte differentiation", Stem Cells Int, 2016, pp.4937689~ (2016)
- Morel L, "Molecular and functional properties of regional astrocytes in the adult brain", J Neurosci, 37, pp.8706~8717 (2017)
- Song JJ, "Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model", J Clin Invest, 128, pp.463~482 (2021)
- Reynolds BA, "A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes", J Neurosci, 12, pp.4565~4574 (1992)
- Qian X, "Brain organoids:advances, applications and challenges", Development, 146, pp.166074~ (2019)
- Lancaster MA, "Generation of cerebral organoids from human pluripotent stem cells", Nature Protoc, 9, pp.2329~2340 (2014)
- Quadrato G, "Cell diversity and network dynamics in photosensitive human brain organoids", Nature, 545, pp.48~53 (2017)
- Lee JH, "Transcriptional signature of valproic acid-induced neural tube defects in human spinal cord organoids", Int J Stem Cells, 16, pp.385~393 (2023)
- Wang LL, "Revisiting astrocyte to neuron conversion with lineage tracing in vivo", Cell, 184, pp.5465~5481 (2021)